Potential effects of propranolol on central nervous system in children with infantile hemangioma

References:

1 Leaute-Labreze C,Harper JI,Hoeger PH.Infantile haemangioma[J].Lancet,2017,390(10089):85-94.DOI:10.1016/s0140-6736(16)00645-0.
2 Ji Y,Chen S,Xiang B,et al.Safety and tolerance of propranolol in neonates with severe infantile hemangiomas:a prospective study[J].Sci Rep,2017,7(1):1503.DOI:10.1038/s41598-017-01321-2.
3 Leaute-Labreze C,Dumas de la Roque E,Hubiche T,et al.Propranolol for severe hemangiomas of infancy[J].New Engl J Med,2008,358(24):2649-2651.DOI:10.1056/NEJMc0708819.
4 Prey S,Voisard JJ,Delarue A,et al.Safety of propranolol therapy for severe infantile hemangioma[J].JAMA,2016,315(4):413-415.DOI:10.1001/jama.2015.13969.
5 Leaute-Labreze C,Hoeger P,Mazereeuw-Hautier J,et al.A randomized,controlled trial of oral propranolol in infantile hemangioma[J].New Engl J Med,2015,372(8):735-746.DOI:10.1056/NEJMoa1404710.
6 Droitcourt C,Kerbrat S,Rault C,et al.Safety of oral propranolol for infantile hemangioma[J].Pediatrics,2018,141(6).DOI:10.1542/peds.2017-3783.
7 Ji Y,Chen S,Xiang B,et al.Clinical features and management of multifocal hepatic hemangiomas in children:a retrospective study[J].Sci Rep,2016,6:31744.DOI:10.1038/srep31744.
8 Al-Majed AA,Bakheit AHH,Abdel Aziz HA,et al.Propranolol[J].Profiles Drug Subst Excip Relat Methodol,2017,42:287-338.DOI:10.1016/bs.podrm.2017.02.006.
9 Tozzi A.Oral propranolol for infantile hemangioma[J].New Engl J Med,2015,373(3):284.DOI:10.1056/NEJMc1503811.
10 Langley A,Pope E.Propranolol and central nervous system function:potential implications for paediatric patients with infantile haemangiomas[J].Brit J Dermatol,2015,172(1):13-23.DOI:10.1111/bjd.13379.
11 Riegel M,Wierzba M,Grabowska A,et al.Effect of emotion on memory for words and their context[J].J Comp Neurol,2016,524(8):1636-1645.DOI:10.1002/cne.23928.
12 Young MP,Scannell JW,Burns GA,et al.Analysis of connectivity:neural systems in the cerebral cortex[J].Rev Neuroscience,1994,5(3):227-250.
13 Pitkanen A,Pikkarainen M,Nurminen N,et al.Reciprocal connections between the amygdala and the hippocampal formation,perirhinal cortex,and postrhinal cortex in rat.A review[J].Ann Ny Acad Sci,2000,911:369-391.
14 Hurlemann R,Walter H,Rehme AK,et al.Human amygdala reactivity is diminished by the beta-noradrenergic antagonist propranolol[J].Psychol Med,2010,40(11):1839-1848.DOI:10.1017/s0033291709992376.
15 Muller U,Mottweiler E,Bublak P.Noradrenergic blockade and numeric working memory in humans[J].J Psychopharmacol,2005,19(1):21-28.DOI:10.1177/0269881105048888.
16 Lonergan MH,Olivera-Figueroa LA,Pitman RK,et al.Propranolol’s effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants:a meta-analysis[J].J Psychiatr Neurosci,2013,38(4):222-231.DOI:10.1503/jpn.120111.
17 Gonzalez-Llorente N,Del Olmo-Benito I,Munoz-Ollero N,et al.Study of cognitive function in children treated with propranolol for infantile hemangioma[J].Pediatr Dermatol,2017,34(5):554-558.DOI:10.1111/pde.13229.
18 Ji Y,Chen S,Wang Q,et al.Intolerable side effects during propranolol therapy for infantile hemangioma:frequency,risk factors and management[J].Sci Rep,2018,8(1):4264.DOI:10.1038/s41598-018-22787-8.
19 Betts TA,Alford C.Beta-blockers and sleep:a controlled trial[J].Eur J Clin Pharmacol,1985,28(1):65-68.
20 Frcka G,Lader M.Psychotropic effects of repeated doses of enalapril,propranolol and atenolol in normal subjects[J].Br J Clin Pharmaco,1988,25(1):67-73.
21 Kostis JB,Rosen RC.Central nervous system effects of beta-adrenergic-blocking drugs:the role of ancillary properties[J].Circulation,1987,75(1):204-212.
22 Marqueling AL,Oza V,Frieden IJ,et al.Propranolol and infantile hemangiomas four years later:a systematic review[J].Pediatr Dermatol,2013,30(2):182-191.DOI:10.1111/pde.12089.
23 Molfese DL,Ivanenko A,Key AF,et al.A one-hour sleep restriction impacts brain processing in young children across tasks:evidence from event-related potentials[J].Dev Neuropsychol,2013,38(5):317-336.DOI:10.1080/87565641.2013.799169.
24 Beebe DW.Cognitive,behavioral,and functional consequences of inadequate sleep in children and adolescents[J].Pediatr Clin North Am,2011,58(3):649-665.DOI:10.1016/j.pcl.2011.03.002.
25 Landauer AA,Pocock DA,Prott FW.Effects of atenolol and propranolol on human performance and subjective feelings[J].Psychopharmacology,1979,60(2):211-215.
26 Famularo R,Kinscherff R,Fenton T.Propranolol treatment for childhood posttraumatic stress disorder,acute type.A pilot study[J].Am J Dis Child,1988,142(11):1244-1247.
27 Mahabir M,Ashbaugh AR,Saumier D,et al.Propranolol’s impact on cognitive performance in post-traumatic stress disorder[J].J Affect Disorders,2016,192:98-103.DOI:10.1016/j.jad.2015.11.051.
28 Salem SA,McDevitt DG.Central effects of single oral doses of propranolol in man[J].Brit J Clin Pharmaco,1984,17(1):31-36.
29 Wang C,Wang Q,Xiang B,et al.Effects of Propranolol on neurodevelopmental outcomes in patients with infantile hemangioma:a case-control study[J].Biomed Res Int,2018,2018:5821369.DOI:10.1155/2018/5821369.
30 Phillips RJ,Penington AJ,Bekhor PS,et al.Use of propranolol for treatment of infantile haemangiomas in an outpatient setting[J].J Paediatr Child Health,2012,48(10):902-906.DOI:10.1111/j.1440-1754.2012.02521.x.
31 Mahon C,Heron G,Perkins D,et al.Oral propranolol for infantile haemangioma may be associated with transient gross motor delay[J].Brit J Dermatol,2018,178(6):1443-1444.DOI:10.1111/bjd.16334.
32 Ji Y,Chen S,Xu C,et al.The use of propranolol in the treatment of infantile haemangiomas:an update on potential mechanisms of action[J].Brit J Dermatol,2015,172(1):24-32.DOI:10.1111/bjd.13388.
33 Ji Y,Wang Q,Chen S,et al.Oral atenolol therapy for proliferating infantile hemangioma:A prospective study[J].Medicine,2016,95(24):e3908.DOI:10.1097/md.0000000000003908.